Yee, S.,
et al., “
Compounded Disparities: Health Equity at the Intersection of Disability, Race, and Ethnicity,”
The National Academies of Sciences, Engineering, and Medicine (
2019):
1–
177,
at 69. There are some empirical studies that tangentially address the intersection of race and SUD as disability without explicitly describing it as such.
See, e.g., W.C. Goedel, et al., “Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States,”
JAMA Network Open 3, no. 4 (2020): e203711 (correlating geographic areas with more non-white residents with methadone treatment availability only and the lower burden buprenorphine access with areas with high numbers of white residents); G. Pro and N. Zaller, “Interaction Effects in the Association Between Methadone Maintenance Therapy and Experiences of Racial Discrimination in U.S. Healthcare Settings,”
PLOS ONE 15, no. 2 (2020): e0228755 (finding that patients who were Black, Hispanic/Latino, or American Indian and who had a history of receiving methadone to treat their substance use disorder were more likely to experience racism in the health care setting than those who had never received methadone).
Google Scholar